Live feed/
Filings
/
SCHEDULE
/
0000078003-25-000005
Stake: 15.00%
Shares: 1,361,709,764
CUSIP: 405552100
Class: Ordinary Shares, nominal value GBP0.01 per share; American Depositary Shares, each representing two Ordinary Shares
Composite Decision Signal · PASS (LOW BASE-RATE EDGE)
Conviction Score: 29/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%
- Filer track record (4 filings): 0% 90d win rate, +0.0% 90d edge
- High conviction ownership stake (15.0%)
- Held by 1 tracked 13F institutional manager
- 4 NPORT-P mutual funds holding CUSIP
- Elevated short days-to-cover (239.1 DTC)
- Short interest building (+27.2% vs prior settlement)
Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby supplemented as follows: Following the closing of the January 2025 Secondary Offering (as defined in Item 6), Pfizer will beneficially own Ordinary Shares (including interests in Ordinary Shares held indirectly through holdings of Restricted ADSs) representing less than 10.0% of the Issuer's outstanding Ordinary Shares. As a result, pursuant to the Pfizer Relationship Agreement, the Pfizer Relationship Agreement will terminate and Pfizer will no longer have the contractual right to nominate representative directors to be appointed to the Board. Mr. Denton previously stepped down from the Board following the closing of the September 2024 Secondary Offering.
Cross-References
Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
8 13D/G filings on this issuer
7 other filings besides this one
Filer Track Record
13 filings by this filer
12 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 239.10
4,914,325 shares short · +27.2% vs prior
Institutional Consensus · 2025-12-31
Held by elite portfolio managers
1 holder · $47.92M
Point72 Asset Mgmt
Post-Filing Returns · since 2025-01-14 on HLNCF
Anchor price 4.84 on closest trading day on/after 2025-01-14. Source: Yahoo Finance daily adj_close (split + dividend adjusted).
Other 13D/G Filings on Haleon plc
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2025-03-24 |
SCHEDULE |
PFIZER INC |
— |
— |
view → |
| 2025-02-27 |
SCHEDULE |
PFIZER INC |
7.30% |
661,709,764 |
view → |
| 2025-01-21 |
SCHEDULE |
PFIZER INC |
7.30% |
661,709,764 |
view → |
| 2024-10-03 |
SC |
PFIZER INC |
— |
— |
view → |
| 2024-10-01 |
SC |
PFIZER INC |
— |
— |
view → |
| 2023-10-10 |
SC |
GSK plc |
— |
— |
view → |
| 2023-10-10 |
SC |
PFIZER INC |
— |
— |
view → |
Other Filings by PFIZER INC
| Filed | Form | Issuer | Stake | Shares | |
|---|
| 2026-10-16 |
SCHEDULE 13G |
PFIZER INC |
— |
— |
view → |
| 2025-03-24 |
SCHEDULE |
Haleon plc HLNCF |
— |
— |
view → |
| 2025-02-27 |
SCHEDULE |
Haleon plc HLNCF |
7.30% |
661,709,764 |
view → |
| 2025-01-21 |
SCHEDULE |
Haleon plc HLNCF |
7.30% |
661,709,764 |
view → |
| 2024-10-03 |
SC |
Haleon plc HLNCF |
— |
— |
view → |
| 2024-10-01 |
SC |
Haleon plc HLNCF |
— |
— |
view → |
| 2024-01-29 |
SC |
Longboard Pharmaceuticals, Inc. |
— |
— |
view → |
| 2024-01-10 |
SC |
Longboard Pharmaceuticals, Inc. |
— |
— |
view → |
| 2023-10-10 |
SC |
Haleon plc HLNCF |
— |
— |
view → |
| 2021-09-17 |
SC |
Allogene Therapeutics, Inc. ALLO |
— |
— |
view → |
| 2021-09-17 |
SC |
Cerevel Therapeutics Holdings, Inc. |
— |
— |
view → |
| 2021-07-09 |
SC |
Cerevel Therapeutics Holdings, Inc. |
— |
— |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →